Cardiovascular risk is a primary concern
There are also other practical reasons to prescribe these drugs in people with type 2 diabetes, because all three classes are associated with relatively low risk of hypoglycemic events, while patients treated with GLP-1RA and SGLT-2 inhibitors may also benefit from weight loss [11]
[5] [6] The American College of Cardiology, American Heart Association, and American Diabetes Association now recommend GLP-1 receptor agonists with proven cardiovascular benefit for patients with type 2 diabetes and established atherosclerotic cardiovascular disease, regardless of baseline hemoglobin A1c levels
Administering the lowest effective microdose and waiting extended periods between dose increases is the standard protocol for reducing gastrointestinal distress in animal models and human trials
If you can eat in, try tackling a fake-a-way recipe to reduce the excess oil and fats that are found in restaurant food without compromising on the treat element
If your pharmacy provided this concentration, consider using the peptide calculator for double-checking your volumes before each injection
